G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
3.910
-0.040 (-1.01%)
Jul 26, 2024, 4:00 PM EDT - Market closed
G1 Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Cash & Equivalents | 19.89 | 32.22 | 94.59 | 221.19 | 207.31 | 269.21 | Upgrade
|
Short-Term Investments | 45.3 | 49.94 | 50.48 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 65.19 | 82.16 | 145.07 | 221.19 | 207.31 | 269.21 | Upgrade
|
Cash Growth | -43.96% | -43.37% | -34.41% | 6.70% | -22.99% | -27.10% | Upgrade
|
Receivables | 11.65 | 12.69 | 11.09 | 5.69 | 0.24 | - | Upgrade
|
Inventory | 12.55 | 12.44 | 16.18 | 3.47 | - | - | Upgrade
|
Prepaid Expenses | 6.39 | 7.6 | 7.09 | 13.16 | 8.79 | 1.73 | Upgrade
|
Restricted Cash | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
Total Current Assets | 95.84 | 114.95 | 179.5 | 243.57 | 216.39 | 271 | Upgrade
|
Property, Plant & Equipment | 5.99 | 6.38 | 7.95 | 9.05 | 10.51 | 13.39 | Upgrade
|
Other Long-Term Assets | 0.2 | 0.21 | 0.51 | 1.48 | 1.65 | 0.44 | Upgrade
|
Total Assets | 102.03 | 121.54 | 187.97 | 254.09 | 228.55 | 284.83 | Upgrade
|
Accounts Payable | 5.11 | 3.99 | 7.43 | 2.9 | 3.57 | 3.68 | Upgrade
|
Accrued Expenses | 17.87 | 21.89 | 25.56 | 23.18 | 16.49 | 15.4 | Upgrade
|
Current Portion of Long-Term Debt | 5.95 | - | - | - | - | - | Upgrade
|
Current Portion of Leases | - | 1.28 | - | - | - | 0.68 | Upgrade
|
Current Unearned Revenue | 0.4 | 0.62 | 0.01 | 0.03 | 0.24 | - | Upgrade
|
Other Current Liabilities | 3.29 | 1.94 | 2.59 | 1.51 | 3.15 | - | Upgrade
|
Total Current Liabilities | 32.6 | 29.72 | 35.59 | 27.61 | 23.44 | 19.77 | Upgrade
|
Long-Term Debt | 37.15 | 51.56 | 77.02 | 75.19 | 19.89 | - | Upgrade
|
Long-Term Leases | 4 | 4.34 | 5.62 | 6.75 | 7.87 | 9.54 | Upgrade
|
Long-Term Unearned Revenue | 0.5 | 0.5 | 1 | 1 | - | - | Upgrade
|
Other Long-Term Liabilities | 0.04 | 0.04 | - | - | - | - | Upgrade
|
Total Liabilities | 74.29 | 86.15 | 119.22 | 110.55 | 51.2 | 29.3 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 817.95 | 815.37 | 800.77 | 728 | 613.46 | 592.38 | Upgrade
|
Retained Earnings | -790.2 | -779.99 | -732.02 | -584.46 | -436.11 | -336.85 | Upgrade
|
Treasury Stock | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
Total Common Equity | 27.74 | 35.39 | 68.75 | 143.54 | 177.35 | 255.53 | Upgrade
|
Shareholders' Equity | 27.74 | 35.39 | 68.75 | 143.54 | 177.35 | 255.53 | Upgrade
|
Total Liabilities & Equity | 102.03 | 121.54 | 187.97 | 254.09 | 228.55 | 284.83 | Upgrade
|
Total Debt | 47.09 | 57.17 | 82.63 | 81.94 | 27.76 | 10.22 | Upgrade
|
Net Cash (Debt) | 18.1 | 24.98 | 62.44 | 139.25 | 179.55 | 258.99 | Upgrade
|
Net Cash Growth | -46.04% | -59.99% | -55.16% | -22.45% | -30.67% | -29.87% | Upgrade
|
Net Cash Per Share | 0.35 | 0.48 | 1.43 | 3.32 | 4.74 | 6.91 | Upgrade
|
Filing Date Shares Outstanding | 52.28 | 52.2 | 51.66 | 42.71 | 41.96 | 37.64 | Upgrade
|
Total Common Shares Outstanding | 52.23 | 51.93 | 51.5 | 42.56 | 38.11 | 37.61 | Upgrade
|
Working Capital | 63.24 | 85.23 | 143.91 | 215.95 | 192.95 | 251.23 | Upgrade
|
Book Value Per Share | 0.53 | 0.68 | 1.33 | 3.37 | 4.65 | 6.79 | Upgrade
|
Tangible Book Value | 27.74 | 35.39 | 68.75 | 143.54 | 177.35 | 255.53 | Upgrade
|
Tangible Book Value Per Share | 0.53 | 0.68 | 1.33 | 3.37 | 4.65 | 6.79 | Upgrade
|
Machinery | 2.03 | 2.03 | 2.03 | 1.53 | 1.53 | 2.27 | Upgrade
|
Leasehold Improvements | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | 1.94 | Upgrade
|
Source: S&P Capital IQ. Standard template.